Evidence map›Paper›PMID 26197342›Full record

ReviewBiomolecules2015

Functional Integration of mRNA Translational Control Programs.

Melanie C MacNicol, Chad E Cragle, Karthik Arumugam, Bruno Fosso, Graziano Pesole, Angus M MacNicol

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Melanie C MacNicolDepartment of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Mel@UAMS.edu.
Chad E CragleInterdisciplinary BioSciences Graduate Program, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. CCragle@uams.edu.
Karthik ArumugamDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Karthik.Arumugam@crg.eu.
Bruno FossoInstitute of Biomembranes and Bioenergetics, National Research Council, Bari 70126, Italy. bruno.fosso@gmail.com.
Graziano PesoleInstitute of Biomembranes and Bioenergetics, National Research Council, Bari 70126, Italy. bruno.fosso@gmail.com.
Angus M MacNicolDepartment of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Angus@UAMS.edu.
University of Arkansas for Medical Sciences · USInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITWinthrop Rockefeller Foundation · US

Funding

PHYSIOLOGICAL DISTURBANCES ASSOCIATED WITH NEONATAL INTRAVENTRICULAR HEMORRHAGEP20RR020146 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI SHEFFER, CHRISTINE ELIZABETH · 2004 to 2011
$17.2M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Telemedicine CoreP30GM110702 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2014 to 2018
$6.1M
Maternal gene regulation in early veterbrate developmentR01HD035688 · NICHD · UNIV OF ARKANSAS FOR MED SCIS · PI MACNICOL, ANGUS M · 1999 to 2011
$2.5M
Arkansas Center for Clinical Translational ResearchKL2TR000063 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$459k
NCATS NIH HHS KL2 TR000063NCATS NIH HHS KL2TR000063NCATS NIH HHS UL1 TR000039NCATS NIH HHS UL1TR000039NCRR NIH HHS P20 RR020146NCRR NIH HHS RR020146NICHD NIH HHS R01 HD035688NICHD NIH HHS R01 HD35688NIGMS NIH HHS P30 GM110702
6 · The paper itself

Abstract

Regulated mRNA translation plays a key role in control of cell cycle progression in a variety of physiological and pathological processes, including in the self-renewal and survival of stem cells and cancer stem cells. While targeting mRNA translation presents an attractive strategy for control of aberrant cell cycle progression, mRNA translation is an underdeveloped therapeutic target. Regulated mRNAs are typically controlled through interaction with multiple RNA binding proteins (RBPs) but the mechanisms by which the functions of distinct RBPs bound to a common target mRNA are coordinated are poorly understood. The challenge now is to gain insight into these mechanisms of coordination and to identify the molecular mediators that integrate multiple, often conflicting, inputs. A first step includes the identification of altered mRNA ribonucleoprotein complex components that assemble on mRNAs bound by multiple, distinct RBPs compared to those recruited by individual RBPs. This review builds upon our knowledge of combinatorial control of mRNA translation during the maturation of oocytes from Xenopus laevis, to address molecular strategies that may mediate RBP diplomacy and conflict resolution for coordinated control of mRNA translational output. Continued study of regulated ribonucleoprotein complex dynamics promises valuable new insights into mRNA translational control and may suggest novel therapeutic strategies for the treatment of disease.

Indexed as

Protein BiosynthesisAnimalsCell CycleHumansMolecular Targeted TherapyRNA-Binding ProteinsRNA-Binding Proteinscombinatorial controlCPEBmRNA translationmRNPMusashiregulationRNA-binding protein

Identifiers

PMID26197342
PMCPMC4598765
OpenAlexW1503334051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.